Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Cinoxate
Cat. No.:
OB0425LY-019
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Cinoxate is a hypertrophic PPARγ agonist.
Synonyms:
104-28-9; Phiasol; Sundare; Cinoxato; 2-Propenoic acid, 3-(4-methoxyphenyl)-, 2-ethoxyethyl ester; 2-Ethoxyethyl-p-methoxycinnamate; 2-Ethoxyethyl (E)-3-(4-methoxyphenyl)prop-2-enoate;
CAS No.:
104-28-9
Compound CID:
5373773
Formula:
C14H18O4
Formula Weight:
250.29
Specification
Target:
PPAR
Pathway:
Cell cycle/DNA damage; Metabolic enzyme/Protease; Vitamin D related/Nuclear receptor
Storage:
Storage at -20°C.
Applications:
Cinoxate has a role in obesity research and novel drug development.
